Welcome to Our Skin, a Personal Discovery Podcast. Each week, host Holly Frey showcases a personal story from someone who lives–and thrives!--while managing psoriasis. Being diagnosed with a chronic skin condition can throw anyone off track, but Our Skin guests have a message of hope: a diagnosis can be an opportunity to discover new things about ourselves, our grit, and our power. In addition to these tales of hope, Frey and her guests plunge into the jaw-dropping, bizarre, and occasionally ...
…
continue reading
MP3•Episode home
Manage episode 490294714 series 3365942
Content provided by Chris Winter, MD, Chris Winter, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chris Winter, MD, Chris Winter, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Weight loss drugs are everywhere and recently Zepbound (tirzepitide) made big news when it became the first FDA-approved sleep apnea therapy for mild to moderate sleep apnea. In this episode, we will:
- Introduce and explain weight loss medications
- Review the studies that convinced the FDA to approve Zepbound for sleep apnea
- Provide an overview on this class of weight loss medications
- Evaluate the risks and determine who is a best match for this therapy
- Touch on the cost and difficulty in getting these drugs approved
- Revisit Apnimed's SynAIRgy press release and how it relates to our discussion in episode 110 of the podcast
Produced by: Maeve Winter
More
- Twitter: @drchriswinter
- IG: @drchriwinter
- Threads: @drchriswinter
- Bluesky: @drchriswinter
- The Sleep Solution and The Rested Child
Thanks for listening and sleep well!
160 episodes